In pancreatic cancer, ablation of SETD2 caused the deletion of CTNNA1, thereby mediating the enhancement of EMT, which strongly suggests that CTNNA1 plays a role in suppressing EMT. Here, CTNNA1 is linked to pancreatic neoplasm.